Abstract Background Glycated hemoglobin (HbA1c), owing to its ability to reflect glycemia
over a relatively longer time span, is still been investigated as an adjunct test for fasting …

Background Over 70% of individuals with type 2 diabetes mellitus (T2DM) may have
metabolic syndrome in sub-Saharan Africa. Evidence about the prevalence, clustering, and …

Aims We examined, in a country of the African region, i) the prevalence of the metabolic
syndrome (MetS) according to three definitions (ATP, WHO and IDF); ii) the distribution of the …

Background. Metabolic syndrome (MetS) is a major public health problem in Sub‐Saharan
Africa. We systematically reviewed the literature towards estimating the prevalence of MetS …

Background. Presence of metabolic syndrome (MetS) in patients with type 2 diabetes
mellitus (type 2 DM) increases the risk of cardiovascular morbidity and mortality. Therefore …

Background. Metabolic syndrome (MS) is a collection of cardiovascular risk factors
comprising insulin resistance, dyslipidemia, obesity, and hypertension, which may cause …

Background Available definition criteria for metabolic syndrome (MS) have similarities and
inconsistencies. The aim of this study was to determine the prevalence of MS in a group of …

The cooccurrence of diabetes mellitus and metabolic syndrome potentiates the
cardiovascular risk associated with each of the conditions; therefore characterizing …

Background and aims Metabolic syndrome (MetS) is a worldwide public health problem,
affecting not just developed countries but also developing countries and impacts all age …

Introduction: Metabolic syndrome (MetS) is a multiplex of risk factors that predispose people
to the development of diabetes and cardiovascular disease (CVD), two of the major non …